Fractional Flow Reserve (FFR)
Diagnostic TestFFR measured by pressure wire, QFR computed by coronary angiographic images
Other names: Quantitative Flow Ratio (QFR)
NCT Number: NCT03191708
Quantitative Flow Ratio (QFR) is a novel method for evaluating the functional significance of coronary stenosis. The purpose of the FAVOR II China study is to evaluate the diagnostic accuracy of on-line QFR with FFR as the reference standard. The secondary purpose is to compare the diagnostic accuracies between online QFR and online QCA, with FFR as the reference standard.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Fuwai Hospital, Beijing, Beijing Municipality, China
Patients at high risk of having one or more coronary stenosis are evaluated routinely by invasive coronary angiography. Lesions are often quantified by QCA, but fractional flow reserve is increasingly used to assess functional significance of identified stenosis. FFR is assessed during CAG by advancing a wire with a pressure transducer towards the stenosis and measure the ratio in pressure between the two sides of the stenosis during medical induced maximum blood flow (hyperemia).
The solid evidence for FFR evaluation of coronary stenosis and the relative simplicity in performing the measurements have supported adoption of an FFR based strategy in many centers but the need for interrogating the stenosis by a pressure wire, the cost of the wire, and the drug inducing hyperemia limits more widespread adoption.
QFR is a novel method for evaluating the functional significance of coronary stenosis by calculation of the pressure drop in the vessel based on two angiographic projections. The FAVOR Pilot study (Tu et al.) showed promising results for core laboratory QFR analysis in selected patients. However, the accuracy of QFR when assessed online in the catheterization laboratory is unknown. The purpose of the FAVOR II China study is to evaluate the diagnostic accuracy of on-line QFR with FFR as the reference standard. The secondary purpose is to compare the diagnostic accuracies between online QFR and online QCA, with FFR as the reference standard. It is a prospective and multi-center trial with a total of 308 patients conducted at 5 Chinese centers.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
General Criteria:
Angiographic inclusion criteria:
Exclusion criteria
General Criteria:
Angiographic exclusion criteria:
FFR measured by pressure wire, QFR computed by coronary angiographic images
Other names: Quantitative Flow Ratio (QFR)
Time frame: 1 hour
Presence of hemodynamically-significant coronary artery stenosis : FFR <= 0.80.
Time frame: 1 hour
Sensitivity: Proportion of patients with positive QFR of FFR positive patients (true positives) compared to proportion of patients with positive percentual diameter stenosis (DS%) assessed by 2D QCA of FFR positive patients (true positives).
Specificity: Proportion of patients with negative QFR of FFR negative patients (true negatives) compared to proportion of patients with negative DS% assessed by 2D QCA of FFR negative patients (true negatives).
Time frame: 1 hour
Time frame: 1 hour
Time frame: 1 hour
Presence of hemodynamically-significant coronary artery stenosis : FFR <= 0.80.
Time frame: 1 hour
Percentage of successful QFR in all vessels sent to QFR computation
China National Center for Cardiovascular Diseases
Other Gov
Functional Diagnostic Accuracy of Quantitative Flow Ratio in On-line Assessment of Coronary Stenosis (The FAVOR II China Study)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07258290
Acute Coronary Syndrome, Angina Pectoris
Washington D.C., District of Columbia, United States
View Trial DetailsNCT04624854
Acute Coronary Syndrome, Arterial Occlusive Diseases
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT04343209
Arterial Occlusive Diseases, Arteriosclerosis
Miami, Florida, United States
View Trial DetailsNCT02057978
Arterial Occlusive Diseases, Arteriosclerosis
Shenyang, Liaoning, China
View Trial Details